Terumo Corp (TUO.MU)
| Previous close | 15.60 |
| Open | 15.60 |
| Bid | 15.70 x 0 |
| Ask | 16.00 x 0 |
| Day's range | 15.60 - 15.60 |
| 52-week range | 12.10 - 18.10 |
| Volume | |
| Avg. volume | 3 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireTerumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System
Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the CDI OneView Monitoring System. The next-generation CDI Systems platform provides visibility of key patient parameters during cardiopulmonary bypass surgery, critical to perfusion safety and improving patient outcomes.
PR NewswireFDA Clears the Individualized Nomogram for Rika Plasma Donation System
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma.
ZacksTerumo (TRUMY) Moves to Strong Buy: Rationale Behind the Upgrade
Terumo (TRUMY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
